Biotech · Private company

Haystack Oncology, Inc.

Track this companyFree. Adds Haystack Oncology, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials44 recruiting or active

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Clinical trials4

Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast CancerNA · RECRUITING · started Aug 22, 2025ClinicalTrials.gov NCT07025785 · fetched Nov 12, 2026
ctDNA in Cutaneous Squamous Cell CarcinomaRECRUITING · started Mar 24, 2025ClinicalTrials.gov NCT06875609 · fetched Nov 12, 2026
Measurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Independent Squamous Cell Carcinoma of the Head and NeckRECRUITING · started Feb 3, 2025ClinicalTrials.gov NCT06744296 · fetched Nov 12, 2026
Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell CarcinomaRECRUITING · started Oct 9, 2024ClinicalTrials.gov NCT06606028 · fetched Nov 12, 2026